Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors
摘要:
A series of N1-activated C4-carboxy azetidinones was prepared and tested as inhibitors of human tryptase. The key stereochemical and functional features required for potency, serine protease specificity and aqueous stability were determined. From these studies compound 2, BMS-262084, was identified as a potent and selective tryptase inhibitor which, when dosed intratracheally in ovalbumin-sensitized guinea pigs, reduced allergen-induced bronchoconstriction and inflammatory cell infiltration into the lung. (C) 2002 Elsevier Science Ltd. All rights reserved.
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors
摘要:
A series of N1-activated C4-carboxy azetidinones was prepared and tested as inhibitors of human tryptase. The key stereochemical and functional features required for potency, serine protease specificity and aqueous stability were determined. From these studies compound 2, BMS-262084, was identified as a potent and selective tryptase inhibitor which, when dosed intratracheally in ovalbumin-sensitized guinea pigs, reduced allergen-induced bronchoconstriction and inflammatory cell infiltration into the lung. (C) 2002 Elsevier Science Ltd. All rights reserved.
Beta lactam compounds and their use as inhibitors of tryptase
申请人:Bristol-Myers Squibb Co.
公开号:US06335324B1
公开(公告)日:2002-01-01
Compounds of the formulas:
are disclosed. These compounds inhibit tryptase as well as other enzyme systems or are selective tryptase inhibitors and are useful as antiinflammatory agents particularly in the treatment of chronic asthma.
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors
作者:James C Sutton、Scott A Bolton、Karen S Hartl、Ming-Hsing Huang、Glenn Jacobs、Wei Meng、Martin L Ogletree、Zulan Pi、William A Schumacher、Steven M Seiler、William A Slusarchyk、Uwe Treuner、Robert Zahler、Guohua Zhao、Gregory S Bisacchi
DOI:10.1016/s0960-894x(02)00688-1
日期:2002.11
A series of N1-activated C4-carboxy azetidinones was prepared and tested as inhibitors of human tryptase. The key stereochemical and functional features required for potency, serine protease specificity and aqueous stability were determined. From these studies compound 2, BMS-262084, was identified as a potent and selective tryptase inhibitor which, when dosed intratracheally in ovalbumin-sensitized guinea pigs, reduced allergen-induced bronchoconstriction and inflammatory cell infiltration into the lung. (C) 2002 Elsevier Science Ltd. All rights reserved.